Bal Pharma Ltd.

101.10 +2.75 ▲2.8%

18 April 2024, 12:21:54 PM
Volume: 4,774

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balpharma.com
Market Cap 157.47 Cr.
Enterprise Value(EV) 289.66 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 2.23 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 44.75 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 40.63 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.45 Calculated using Price: 99.61
Dividend Yield 1.00 Period Ending 2023-03
No. of Shares Subscribed 1.58 Cr. 15,808,372 Shares
FaceValue 10
About Bal Pharma Ltd.
Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.

Bal Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Bal Pharma Ltd. Performance

1 Day
+2.80%
1 Week
-0.59%
1 Month
+6.76%
3 Month
-11.35%
6 Month
+9.06%
1 Year
+41.20%
2 Year
-11.74%
5 Year
+40.12%
10 Year
+203.60%

Bal Pharma Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7 0.49 -0.69 0.59 3.27 -21.65 8.97 10.34 4.31
Return on Capital Employed (%) 10.88 7.35 7.59 7.45 6.88 -0.44 9.72 12.33 9.56
Return on Assets (%) 2.23 0.14 -0.18 0.15 0.83 -5.16 1.97 2.28 0.92

Bal Pharma Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 55 55 62 65 67 52 54 59 64 63
Non Curr. Liab. 16 45 30 46 38 34 34 36 38 36
Curr. Liab. 92 111 143 154 163 159 153 166 209 229
Minority Int. 0 0 -2 -5 -6 -7 0 0 0 0
Equity & Liab. 164 211 233 260 261 238 240 261 311 328
Non Curr. Assets 59 68 69 75 78 81 76 76 83 83
Curr. Assets 105 143 165 185 183 157 164 185 228 244
Misc. Exp. not W/O
Total Assets 164 211 233 260 261 238 240 261 311 328

Bal Pharma Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 187 198 229 209 225 171 251 281 304 327
Other Income 1 1 3 2 1 2 1 5 1 1
Total Income 188 200 232 211 226 173 252 286 305 328
Total Expenditure -170 -183 -214 -192 -207 -166 -226 -257 -279 -297
PBIDT 18 16 18 19 19 7 26 29 26 31
Interest -7 -6 -8 -9 -13 -13 -12 -11 -12 -15
Depreciation -7 -7 -6 -7 -6 -8 -10 -9 -9 -10
Taxation -1 -2 -3 -3 2 1 1 -3 -2 -2
Exceptional Items
PAT 4 0 0 0 2 -13 5 6 3 4
Minority Interest 0 1 2 2 2 1 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 4 1 2 3 4 -12 5 6 3 4
Adjusted EPS 3 1 1 2 3 -9 3 4 2 2

Bal Pharma Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 13 15 -19 6 1 8 23 22 27 -2
Cash Fr. Inv. -7 -5 -14 -8 -4 -8 -5 -6 -9 -22
Cash Fr. Finan. -8 -7 32 -6 4 0 -20 -17 -17 24
Net Change -2 2 -1 -8 1 0 -1 0 0 0
Cash & Cash Eqvt 3 5 5 -25 3 2 1 1 1 1

Bal Pharma Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 49.57 52.00 52.00 51.61 51.61 51.61 51.61 51.23 51.23
Public 50.43 48.00 48.00 48.39 48.39 48.39 48.39 48.77 48.77
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Bal Pharma Ltd. Announcements

Wed, 17 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
BAL PHARMA LIMITED has informed the Exchange about Loss of share certificates
Wed, 17 Apr 2024
Loss of Share Certificates
Bal Pharma Limited has informed the Exchange about Loss of Share Certificates
Fri, 05 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bal Pharma Ltd. Technical Scans

Tue, 16 Apr 2024
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
CCI Trending Down CCI Trending Down
Close Crossing 20 SMA From Above Close Crossing 20 SMA From Above

Bal Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 368,765.79 1,540.30 +0.2%
Cipla Ltd. 111,101.58 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. 100,958.41 6,087.05 +0.6%
Divi's Laboratories Ltd. 99,939.63 3,745.45 -0.5%
Zydus Lifesciences Ltd. 95,104.21 946.45 +0.2%
Mankind Pharma Ltd. 91,420.29 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. 91,073.20 6,250.00 -1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.41 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-12 29.96 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.31 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.26 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.98 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-12 52.93 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.38 6,250.00 -1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.91 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-12 4.29 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.76 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.67 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.05 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.29 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.48 6,250.00 -1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,250.00 -1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,250.00 -1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,250.00 -1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,250.00 -1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,540.30 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,375.70 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,087.05 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,745.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 946.45 +0.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,368.30 +3.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,250.00 -1.3%

Bal Pharma Ltd. FAQ's

What is Bal Pharma share price?

Can I buy Bal Pharma shares now?

What is the Dividend Yield of Bal Pharma?

What is the Market Cap of Bal Pharma?

What are the key metrics to analyse Bal Pharma?

What is the 52 Week High and Low of Bal Pharma?

What is the trend of Bal Pharma share price?